Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
Objective: We aim to characterize the incidence and relative risk of rheumatic and systemic immune-related adverse effects (irAEs) among immune checkpoint inhibitor (ICI) therapy compared with those after placebo treatment. Methods: Randomized clinical trial studies with placebo control with the fol...
Saved in:
Main Authors: | Shuo Zhang (Author), Ziyue Zhou (Author), Li Wang (Author), Mengtao Li (Author), Fengchun Zhang (Author), Xiaofeng Zeng (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series
by: Antonella Laria, et al.
Published: (2021) -
Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
by: Hao Liu, et al.
Published: (2023) -
A model‐based meta‐analysis of immune‐related adverse events during immune checkpoint inhibitors treatment for NSCLC
by: Renwei Zhang, et al.
Published: (2022) -
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
by: Zoe Apalla, et al.
Published: (2021) -
Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study
by: Chunhong Zhang, et al.
Published: (2024)